Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors

Recently, modulation of immune checkpoints has risen to prominence as a means to treat a number of solid malignancies, given the durable response seen in many patients and improved side effect profile compared to conventional chemotherapeutic agents. Several classes of immune checkpoint modulators h...

Descripción completa

Detalles Bibliográficos
Autores principales: Gravbrot, Nicholas, Gilbert-Gard, Kacy, Mehta, Paras, Ghotmi, Yarah, Banerjee, Madhulika, Mazis, Christopher, Sundararajan, Srinath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963985/
https://www.ncbi.nlm.nih.gov/pubmed/31640266
http://dx.doi.org/10.3390/antib8040051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963985/
https://www.ncbi.nlm.nih.gov/pubmed/31640266
http://dx.doi.org/10.3390/antib8040051

Ejemplares similares